Cartwright G E, Edwards C Q, Skolnick M H, Amos D B
J Clin Invest. 1980 May;65(5):989-92. doi: 10.1172/JCI109785.
Five of seven patients with idiopathic refractory sideroblastic anemia carried an HLA-A3 alloantigen (relative risk, 7.3; P = 0.02). The significance of this association was strengthened by study of two pedigrees. An abnormality in iron metabolism was found in two siblings who had an HLA-A3,B14 haplotype in common with the first proband. A second proband with idiopathic refractory sideroblastic anemia had clinically manifest hemochromatosis. His brother had clinically manifest hemochromatosis but not sideroblastic anemia. This proband and his brother shared only the HLA-A3,B12 haplotype. Our findings infer that patients with idiopathic refractory sideroblastic anemia carry a single allele for hemochromatosis, that this allele accounts for the increased iron loading in this form of anemia, and that clinically manifest hemochromatosis may develop in an occasional patient with only one allele for hemochromatosis in the presence of the sideroblastic factor.
7例特发性难治性铁粒幼细胞贫血患者中有5例携带HLA - A3同种抗原(相对危险度为7.3;P = 0.02)。对两个家系的研究进一步证实了这种关联的重要性。在两名与首例先证者共有HLA - A3、B14单倍型的同胞中发现了铁代谢异常。另一名患有特发性难治性铁粒幼细胞贫血的先证者有临床症状明显的血色素沉着症。他的兄弟有临床症状明显的血色素沉着症,但没有铁粒幼细胞贫血。该先证者与其兄弟仅共有HLA - A3、B12单倍型。我们的研究结果表明,特发性难治性铁粒幼细胞贫血患者携带一个血色素沉着症等位基因,该等位基因导致了这种贫血中铁负荷增加,并且在存在铁粒幼细胞因素的情况下,偶尔有仅携带一个血色素沉着症等位基因的患者可能会出现临床症状明显的血色素沉着症。